Viewing Study NCT05073250


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2026-01-03 @ 10:03 AM
Study NCT ID: NCT05073250
Status: UNKNOWN
Last Update Posted: 2023-05-12
First Post: 2021-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
Sponsor: Chinese PLA General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inert Non Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PI3K inhibitor View
None rituximab View
None follicular lymphoma View
None marginal zone lymphoma View